Arm vs. Micron: Which AI Stock Is a Better Buy?

Arm announced it is designing its own AGI CPU with Meta as lead partner and expects the new chip unit could generate $15 billion in annual sales within five years; Arm reported fiscal Q3 FY2026 revenue of $1.24 billion, up 26% YoY. Micron reported fiscal Q2 revenue of about $23.9 billion, up 196% YoY, with adjusted EPS of $12.20 and guided FYQ3 revenue of roughly $33.5 billion, yet the stock fell amid concerns over memory cyclicality. Valuation spread is wide (Micron forward P/E ~8 vs. Arm in the seventies), implying Micron faces cyclical downside risk while Arm's silicon pivot may provide a more durable long-term growth driver.

Analysis

Arm’s pivot from an IP-licensing royalty model into owning silicon will re-write competitive linkages across the stack: lead partners like Meta gain optionality (supply and integration control) while traditional licensees and foundries face incentive conflicts that could accelerate fragmentation toward alternatives (RISC‑V, in‑house designs). Winning requires Arm to master wafer economics and software optimization simultaneously; delays in either dimension materially compress the implicit premium investors are paying today.

Micron’s current pricing power looks susceptible to an industry rhythm — high margins prompt capacity responses with a 12–36 month lag, after which ASPs typically rebase lower; unless structural HBM supply constraints persist beyond current buildout cycles, expect pronounced earnings volatility over the next 6–24 months. That dynamic creates a convex payoff: outsized upside if scarcity persists, but asymmetric downside if capex normalizes faster than expected.

Two second‑order implications: 1) Arm taking share of silicon revenue could lift total system economics for CPU incumbents but also commoditize parts of the royalty stream, forcing license renegotiations; 2) Micron’s cash cushion from today’s cycle can fund share buybacks or defensive capex, muting the timing of any price collapse. The market appears to be pricing a binary outcome for both names — execution for Arm over several years, and mean‑reversion for Micron within a couple of years — creating distinct tradeable risk/reward asymmetries.

Key Decisions for Investors

• Buy ARM long-dated call spread (18–24 month LEAPs): buy-to-open ATM LEAP call and sell to open a higher strike to fund ~50–70% of premium. Size 2–3% of strategy; objective is to capture multi-year upside while capping downside to premium. Rationale: pays off if Arm converts silicon ambition to material revenue within 2–4 years; pain if execution stalls or margin compresses.
• Pair trade — Long ARM / Short MU (equal notional, 12–24 month horizon): go long ARM equity exposure (or LEAP) and short Micron equity to neutralize market beta. Target skew to favor ARM by 10–20% notional; stop-loss if relative moves >25% vs entry. This isolates secular vs cyclical exposure and benefits if Arm’s structural capture materializes while Micron mean-reverts.
• Buy MU 6–12 month puts as a hedge/spec short (small allocation, 0.5–1% of strategy): purchase ATM or slightly OTM puts to protect against HBM pricing collapse or faster-than-expected supply additions. Reward is high if memory ASPs correct; loss limited to premium paid.
• Buy META 12–18 month call (selective, 1–2%): asymmetric hedge to Arm execution — if Meta’s integration advantage accelerates, ownership/partner optionality lifts Meta’s data-center economics. Exit or re-evaluate on clear signs of Arm supply reliability (first silicon delivery + published power/yield targets).